Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Aurobindo Pharma Ltd.
NSE: AUROPHARMA
|
BSE: 524804
|
ISIN: INE406A01037
|
Industry: Pharmaceuticals
|
Mid-range Performer
1157.2000
-10.40
(
-0.89
%)
NSE
Jan 20, 2026
12:55 PM
Volume:
249.8K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Aurobindo Pharma Ltd.
06 Aug 2025
1157.20
-0.89%
Result Update:Aurobindo Pharma
Buy:
Aurobindo Pharma Ltd.
by
Axis Direct
Target: 1400 | Upside : 21.0%
Target
Axis Direct
We maintain our BUY recommendation on the stock with a TP of Rs 1,400/share.
Aurobindo Pharma Ltd. has an
average target
of 1349.22 from 9 brokers.
More from Aurobindo Pharma Ltd.
Recommended
Market trades lower, Archean Chemical's board appoints Rampraveen Swaminathan as the MD
Trendlyne Marketwatch |
20 Jan 2026, 12:52PM
Primary market stays busy with 12 companies set to go public
|
19 Jan 2026, 05:56PM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
|
15 Jul 2020